Cancer Care Can’t Wait

Colorectal cancer screening remains a priority amidst COVID-19
Rutgers Cancer Institute of New Jersey

Newswise — New Brunswick, N.J., July 27, 2020 –The presence of COVID-19 has caused many people to fear venturing out for vital medical services like cancer screenings. According to projections from the National Cancer Institute, disruptions in routine cancer care due to the pandemic could lead up to an excess 10,000 deaths from breast and colorectal cancers. Most colorectal cancers can be prevented through regular screening through detection and removal of polyps, so it is important to follow through with appointments for essential care, even during this challenging time. We are doing everything possible to make it safe for our patients to return to getting their important medical care.

Colorectal cancer is the third most common type of cancer in both men and women, according to the American Cancer Society. It may lead to blood in the stool but frequently does not cause any symptoms until it is advanced and starts to spread through the body. If diagnosed at a later stage, the disease can be more challenging to treat.

Colorectal cancer screening is used to detect cancer and remove precancerous polyps. It is typically recommended by the American Cancer Society that colorectal cancer screening for men and women should begin at age 45 and repeated every ten years for those of average risk. Those with a family history and other underlying conditions should speak with their health care provider to determine what screening regimen is appropriate for them. If screening detects an abnormality, diagnosis and treatment can occur quickly. Finding and removing early stage colon cancers is almost always curative. Cancers that have spread beyond the colon or rectum can be much more difficult to treat.  

Rutgers Cancer Institute of New Jersey in partnership with RWJBarnabas Health are hard at work to provide this sort of care close to home and minimize the risk of patients and other healthcare workers from developing COVID-19. We are working hard to reduce risks by screening all patients and clinical employees, following social distancing measures, and enhancing rigorous cleaning practices among other ways in which we maintain a safe environment for you and all patients.

Schedule an Appointment

To help reduce the incidence of colorectal cancer, ScreenNJ was developed under the leadership of Rutgers Cancer Institute of New Jersey in partnership with the New Jersey Department of Health. The initiative is a collaboration of organizations across the state committed to improving cancer screening, prevention and education. This resource can be utilized to find local colorectal (as well as lung) cancer screening programs and information about the types of testing and benefits. And for those who may be in need of further examination stemming from a colonoscopy, new patient appointments can be made with one of our cancer specialists by calling 844-CANCERNJ (844-226-2376) or visiting rwjbh.org/beatcancer.

Howard S. Hochster, MD, FACP, is the Associate Director for Clinical Research and Director, Gastrointestinal Oncology Program, Rutgers Cancer Institute of New Jersey; and Director of Oncology Research, RWJBarnabas Health.




Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health
Cedars-Sinai

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4146

close
1.2856